ROP Stock Analysis: Roper Technologies | NASDAQ

Software - Application | NASDAQ, USA | Market Cap: 39.272m USD | 12M Return: -23.3% | US7766961061 | Charts, Fundamentals & Technical Analysis

Application Software, Network Software, Medical Devices, Sensor
Total Rating 45
Safety 73
Buy Signal 1.05
Software - Application
Industry Rotation: +7.2
Market Cap: 39.3B
Avg Turnover: 322M
Risk 3d forecast
Volatility23.2%
VaR 5th Pctl4.12%
VaR vs Median8.23%
Reward TTM
Sharpe Ratio-0.93
Rel. Str. IBD41.6
Rel. Str. Peer Group46.1
Character TTM
Beta-0.096
Beta Downside0.069
Hurst Exponent0.469
Drawdowns 3y
Max DD46.51%
CAGR/Max DD-0.12
CAGR/Mean DD-0.44
EPS (Earnings per Share) EPS (Earnings per Share) of ROP over the last years for every Quarter: "2021-06": 3.76, "2021-09": 3.91, "2021-12": 3.73, "2022-03": 3.77, "2022-06": 3.95, "2022-09": 3.67, "2022-12": 3.92, "2023-03": 3.9, "2023-06": 4.12, "2023-09": 4.32, "2023-12": 4.37, "2024-03": 4.41, "2024-06": 4.48, "2024-09": 4.62, "2024-12": 4.81, "2025-03": 4.78, "2025-06": 4.87, "2025-09": 5.14, "2025-12": 5.21, "2026-03": 5.16, "2026-06": 5.38,
EPS CAGR: 9.29%
EPS Trend: 99.9%
Last SUE: 1.81
Qual. Beats: 8
Revenue Revenue of ROP over the last years for every Quarter: 2021-06: 1189.8, 2021-09: 1232.1, 2021-12: 1256.6, 2022-03: 1279.8, 2022-06: 1310.8, 2022-09: 1350.3, 2022-12: 1430.9, 2023-03: 1469.7, 2023-06: 1531.2, 2023-09: 1563.4, 2023-12: 1613.5, 2024-03: 1680.7, 2024-06: 1716.8, 2024-09: 1764.6, 2024-12: 1877.1, 2025-03: 1882.8, 2025-06: 1943.6, 2025-09: 2017.5, 2025-12: 2058.6, 2026-03: 2095.3, 2026-06: 2108.9,
Rev. CAGR: 12.81%
Rev. Trend: 99.9%
Last SUE: 0.44
Qual. Beats: 0

Warnings

No concerns identified

Tailwinds

Confidence

Seasonality 11.6 years of data

Jan -0.4% 10
Feb -0.9% 19
Mar +1.8% 22
Apr +0.5% 5
May +0.5% 15
Jun +1.2% 8
Jul +2.5% 19
Aug -2.3% 32
Sep -4.2% 48
Oct -3.9% 28
Nov +4.3% 50
Dec -0.3% 0

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: ROP Roper Technologies

Roper Technologies, Inc. (NASDAQ: ROP) is a diversified technology company that designs and develops vertical market software and technology-enabled products, operating across the United States, Canada, Europe, Asia, and other international markets. The company reports through three segments: Application Software (covering management, diagnostic and laboratory information, K-12 school administration, transportation, financial compliance, payment processing, foodservice technologies, and property & casualty insurance software); Network Software (offering cloud-based data, collaboration, electronic marketplace, visual effects/3D content, supply chain, healthcare, pharmacy, and AI-enabled SaaS solutions, including offerings for life insurance, financial services, and faith-based organizations); and Technology Enabled Products (including ultrasound accessories, dispensers and metering pumps, wireless sensors, surgical scrub and linen dispensing equipment, water meters, optical/electromagnetic measurement systems, RFID readers, and medical devices). Products are sold through direct sales offices, manufacturers representatives, resellers, and distributors. The company was incorporated in 1981, is headquartered in Sarasota, Florida, and was renamed from Roper Industries, Inc. to Roper Technologies, Inc. in April 2015.

Note on sector and business model: Roper is classified under the GICS Industrials sector and Industrial Conglomerates sub-industry, even though the bulk of its current revenue comes from software. Its vertical market software approach means the company builds purpose-built solutions tailored to the workflows of specific end industries (such as healthcare, insurance, education, and food service) rather than horizontal, one-size-fits-all enterprise software, and the business has historically been shaped by an acquisition-driven strategy of rolling up niche, asset-light software businesses.

Headlines to Watch Out For
  • Vertical software acquisitions continue driving capital deployment strategy
  • Network Software segment growth offsets Technology Enabled Products decline
  • High interest rates pressure M&A financing and deal activity
Piotroski VR-10 (Strict) 5.0
Net Income: 2.50b TTM > 0 and > 6% of Revenue
FCF/TA: 0.07 > 0.02 and ΔFCF/TA 0.47 > 1.0
NWC/Revenue: -18.74% < 20% (prev -25.58%; Δ 6.83% < -1%)
CFO/TA 0.08 > 3% & CFO 2.67b > Net Income 2.50b
Net Debt (11.0b) to EBITDA (3.24b): 3.40 < 3
Current Ratio: 0.55 > 1.5 & < 3
Outstanding Shares: last quarter (102.6m) vs 12m ago -5.35% < -2%
Gross Margin: 69.53% > 18% (prev 68.87%; Δ 0.66% > 0.5%)
Asset Turnover: 24.21% > 50% (prev 22.48%; Δ 1.73% > 0%)
Interest Coverage Ratio: 5.88 > 6 (EBIT TTM 2.32b / Interest Expense TTM 393.7m)
Altman Z'' 3.09
A: -0.04 (Total Current Assets 1.92b - Total Current Liabilities 3.47b) / Total Assets 35.2b
B: 0.53 (Retained Earnings 18.7b / Total Assets 35.2b)
C: 0.07 (EBIT TTM 2.32b / Avg Total Assets 34.2b)
D: 1.14 (Book Value of Equity 18.7b / Total Liabilities 16.5b)
Altman-Z'' = 3.09 = A
Beneish M -2.97
DSRI: 0.98 (Receivables 1.15b/1.06b, Revenue 8.28b/7.47b)
GMI: 0.99 (GM 68.87% / 69.53%)
AQI: 1.00 (AQ_t 0.94 / AQ_t-1 0.95)
SGI: 1.11 (Revenue 8.28b / 7.47b)
TATA: -0.00 (NI 2.50b - CFO 2.67b) / TA 35.2b)
Beneish M = -2.97 (Cap -4..+1) = A
What is the price of ROP shares?

As of August 15, 2026, the stock is trading at USD 399.34 with a total of 733,613 shares traded. Over the past week, the price has changed by -0.72%, over one month by +15.20%, over three months by +25.91% and over the past year by -23.26%.

Current recommended Stop Loss: 382.00 (which is 4.3% or 1.4 ATR below the current price).

Is ROP a buy, sell or hold?

Roper Technologies has received a consensus analysts rating of 4.11. Therefore, it is recommended to buy ROP.

  • StrongBuy: 10
  • Buy: 2
  • Hold: 6
  • Sell: 1
  • StrongSell: 0

What are the forecasts/targets for the ROP price?
Analysts Target Price 440.3 10.2%
Roper Technologies (ROP) - Fundamental Data Overview as of 08 August 2026
Market Cap USD = 39.3b (39.3b USD * 1.0 USD.USD)
P/E Trailing = 16.449
P/E Forward = 17.8891
P/S = 4.7428
P/B = 2.0772
P/EG = 1.7127
Revenue TTM = 8.28b USD
EBIT TTM = 2.32b USD
EBITDA TTM = 3.24b USD
Long Term Debt = 10.6b USD (from longTermDebt, last quarter)
Short Term Debt = 718.3m USD (from shortTermDebt, last quarter)
Debt = 11.4b USD (from shortLongTermDebtTotal, last quarter) + Leases 48.3m
Net Debt = 11.0b USD (calculated: Debt 11.4b - CCE 364.9m)
Enterprise Value = 50.3b USD (39.3b + Debt 11.4b - CCE 364.9m)
Interest Coverage Ratio = 5.88 (Ebit TTM 2.32b / Interest Expense TTM 393.7m)
EV/FCF = 19.17x (Enterprise Value 50.3b / FCF TTM 2.62b)
FCF Yield = 5.22% (FCF TTM 2.62b / Enterprise Value 50.3b)
FCF Margin = 31.67% (FCF TTM 2.62b / Revenue TTM 8.28b)
Net Margin = 30.24% (Net Income TTM 2.50b / Revenue TTM 8.28b)
Gross Margin = 69.53% ((Revenue TTM 8.28b - Cost of Revenue TTM 2.52b) / Revenue TTM)
Gross Margin QoQ = 69.71% (prev 69.38%)
Tobins Q-Ratio = 1.43 (Enterprise Value 50.3b / Total Assets 35.2b)
Interest Expense / Debt = 3.46% (Interest Expense 393.7m / Debt 11.4b)
Taxrate = 15.84% (471.5m / 2.98b)
NOPAT = 1.95b (EBIT 2.32b * (1 - 15.84%))
Current Ratio = 0.55 (Total Current Assets 1.92b / Total Current Liabilities 3.47b)
Debt / Equity = 0.61 (Debt 11.4b / totalStockholderEquity, last quarter 18.7b)
Debt / EBITDA = 3.40 (Net Debt 11.0b / EBITDA 3.24b)
Debt / FCF = 4.20 (Net Debt 11.0b / FCF TTM 2.62b)
Total Stockholder Equity = 19.3b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.32% (Net Income 2.50b / Total Assets 35.2b)
RoE = 12.94% (Net Income TTM 2.50b / Total Stockholder Equity 19.3b)
RoCE = 7.73% (EBIT 2.32b / Capital Employed (Equity 19.3b + L.T.Debt 10.6b))
RoIC = 6.08% (NOPAT 1.95b / Invested Capital 32.1b)
WACC = 5.04% (E(39.3b)/V(50.6b) * Re(5.65%) + D(11.4b)/V(50.6b) * Rd(3.46%) * (1-Tc(0.16)))
Discount Rate = 5.65% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -66.98 | Cagr: -2.21%
[DCF] Terminal Value 77.65% ; FCFF base≈2.50b ; Y1≈2.82b ; Y5≈3.97b
[DCF] Fair Price = 494.9 (EV 60.0b - Net Debt 11.0b = Equity 48.9b / Shares 98.9m; r=8.35% [WACC [floored]]; 5y FCF grow 12.97% → 2.50% )
EPS Correlation: 99.91 | EPS CAGR: 9.29% | SUE: 1.81 | # QB: 8
Revenue Correlation: 99.87 | Revenue CAGR: 12.81% | SUE: 0.44 | # QB: 0
EPS current Quarter (2026-09-30): EPS=5.79 | Chg30d=+2.46% | Revisions=+81% | Analysts=16
EPS current Year (2026-12-31): EPS=22.22 | Chg30d=+1.32% | Revisions=+67% | GrowthEPS=+11.1% | GrowthRev=+8.4%
EPS next Year (2027-12-31): EPS=24.26 | Chg30d=+1.59% | Revisions=+18% | GrowthEPS=+9.2% | GrowthRev=+6.1%
[Analyst] Revisions Ratio: +70% (up=24, down=3)